The estimated Net Worth of Nechemia Jacob Peres is at least 1.41 百万$ dollars as of 14 June 2022. Mr. Peres owns over 14,479 units of Teva- Pharmaceutical Industries stock worth over 1,055,419$ and over the last 6 years he sold TEVA stock worth over 0$. In addition, he makes 355,762$ as Independent Director at Teva- Pharmaceutical Industries.
Nechemia has made over 5 trades of the Teva- Pharmaceutical Industries stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 14,479 units of TEVA stock worth 260,043$ on 14 June 2022.
The largest trade he's ever made was exercising 17,621 units of Teva- Pharmaceutical Industries stock on 11 June 2020 worth over 316,473$. On average, Nechemia trades about 5,877 units every 73 days since 2018. As of 14 June 2022 he still owns at least 58,765 units of Teva- Pharmaceutical Industries stock.
You can see the complete history of Mr. Peres stock trades at the bottom of the page.
Nechemia (Chemi) Jacob Peres serves as Independent Director of the Company. Mr. Peres serves as the managing general partner and co-founder of Pitango Venture Capital, Israel’s largest venture capital group. Pitango invests in technology companies across technology sectors, from IT to healthcare, with over 220 portfolio company investments since its inception in 1996. Mr. Peres serves on the board of directors of numerous Pitango portfolio companies. Mr. Peres is also the founder of Mofet Israel Technology Fund, one of Israel’s first venture capital funds, founded in 1992. Mr. Peres is chairman of the Peres Center for Peace and Innovation. He co-founded and chaired the Israel Venture Association (IATI—Israel Advanced Technology Industries) and he chaired the Israel America Chamber of Commerce from 2008 to 2011.
As the Independent Director of Teva- Pharmaceutical Industries, the total compensation of Nechemia Peres at Teva- Pharmaceutical Industries is 355,762$. There are 11 executives at Teva- Pharmaceutical Industries getting paid more, with Kaare Schultz having the highest compensation of 11,596,600$.
Nechemia Peres is 61, he's been the Independent Director of Teva- Pharmaceutical Industries since 2017. There are 5 older and 24 younger executives at Teva- Pharmaceutical Industries. The oldest executive at Teva- Pharmaceutical Industries Ltd. is Gerald Lieberman, 73, who is the Independent Director.
Nechemia's mailing address filed with the SEC is C/O TEVA PHARMACEUTICAL INDUSTRIES LTD., 124 DVORA HANEVI'A ST.,, TEL AVIV, L3, 6944020.
Over the last 7 years, insiders at Teva- Pharmaceutical Industries have traded over 31,332,399$ worth of Teva- Pharmaceutical Industries stock and bought 967,500 units worth 16,473,820$ . The most active insiders traders include Sol J Barer、Tal Zvi Zaks、Roberto Mignone. On average, Teva- Pharmaceutical Industries executives and independent directors trade stock every 9 days with the average trade being worth of 636,538$. The most recent stock trade was executed by Varda Shalev on 2 September 2024, trading 12,872 units of TEVA stock currently worth 231,181$.
Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company with headquarters in Tel Aviv, Israel. It specializes primarily in generic drugs, but other business interests include active pharmaceutical ingredients and, to a lesser extent, proprietary pharmaceuticals.
Teva- Pharmaceutical Industries executives and other stock owners filed with the SEC include: